Submit a Manuscript to the Journal

Human Vaccines & Immunotherapeutics

For an Article Collection on

Personal cancer immunotherapy

Manuscript deadline
01 November 2023

Cover image - Human Vaccines & Immunotherapeutics

Article collection guest advisor(s)

Robert Dillman, AIVITA Biomedical, California, USA
[email protected]

Submit an ArticleVisit JournalArticles

Personal cancer immunotherapy

Immunotherapy is now firmly established as a therapeutic modality for the treatment of malignancy. Because of inherent interpatient heterogeneity of the tumor and immune systems, there is increasing interest in personalized and personal immunotherapies. This collection focuses on “personal” anti-cancer immunotherapies, i.e., those that are manufactured using autologous immune cells and/or autologous tumor cells and their antigens. Examples include autologous adoptive cellular therapies such as tumor infiltrating lymphocytes (TIL), natural killer (NK) cells, and lymphocytes modified by chimeric antigen receptor (CAR-T), or T cell receptor (TCR) engineering, as well as autologous dendritic cells (DC) and/or autologous tumor cells, their antigens, or mRNA. The initial emphasis of the Collection has been on expert reviews, but may also include original research and commentaries. The Collection is still open for new submissions. We accept articles investigating:

  • Autologous (not allogeneic) cell-based therapies
  • The role of various immune cell types in immunotherapy
  • Personalized neoantigens for autologous cell treatment
  • Preclinical models, trial design and regulatory issues

Submission information:

  • Select "Personal and personalized cancer immunotherapy" when submitting your paper to the Submission Portal
  • Research papers, Reviews and Commentaries will be considered for publication
  • Papers will be published online as they are accepted

Benefits of publishing open access within Taylor & Francis

Global marketing and publicity, ensuring your research reaches the people you want it to.

Article Collections bring together the latest research on hot topics from influential researchers across the globe.

Rigorous peer review for every open access article.

Rapid online publication allowing you to share your work quickly.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.